Cytek Biosciences Inc. logo

Cytek Biosciences Inc.

CTKB | NASDAQ
Chart Builder DCF Calculator
$5.55
+$0.27 (+5.11%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
48.14M 44.14M 62.14M 52.29M 45.6M 41.46M 57.48M 51.5M 46.62M 44.86M 58.23M 48M 49.69M 37.09M 48.34M 40.48M 40.16M 35.06M 38.89M 34.38M 30.41M 24.27M
Cost of Revenue
19.8M 22.88M 29.26M 24.74M 21.74M 21.3M 23.82M 22.5M 21.18M 21.85M 25.19M 20.82M 21.53M 16.05M 18.96M 13.62M 15.6M 14.89M 15.26M 13.1M 10.66M 9.79M
Gross Profit
28.34M 21.25M 32.89M 27.55M 23.87M 20.16M 33.65M 29.01M 25.44M 23.01M 33.05M 27.18M 28.16M 21.04M 29.37M 26.86M 24.56M 20.18M 23.64M 21.28M 19.75M 14.49M
Operating Income
-11.4M -18.46M -5.59M -9.19M -10.62M -14.98M 2.99M -4.25M -8.53M -10.73M -137K -6.42M -9.13M -12.16M 84K 1.36M -891K -2.36M 1.32M 2.9M 3.81M 1.13M
Interest Income
819K 787K 580K 573K 555K 508K 6.15M 1.43M 1.42M 1.36M 1.45M 1.62M 1.2M 2.14M 2.63M 1.58M 391K 18K 18K 12K 9K 10K
Pretax Income
-11.64M -17.37M -4.03M -7.77M -6.78M -11.27M 10.32M 157K -7.19M -8.99M 4.11M -4.19M -6.6M -9.04M 4.11M 1.85M -1.4M -3.3M 444K 2.08M 3.27M 152K
Net Income
-12.16M -18.87M -44.08M -5.48M -5.58M -11.4M 9.64M 941K -10.43M -6.17M 5.5M -6.46M -4.39M -6.81M 3.53M 1.67M -598K -2.02M -1.19M 1.42M 2.67M 102K
Selling & General & Admin
30M 30.11M 29.52M 27.79M 25.67M 25.41M 20.94M 23.37M 23.96M 23.95M 22.32M 22.43M 25.15M 23.23M 19.54M 16.85M 17.02M 14.51M 15.24M 12.3M 9.74M 8.26M
Research & Development
9.74M 9.6M 8.96M 8.96M 8.83M 9.73M 9.72M 9.88M 10M 9.8M 10.87M 11.17M 12.14M 9.97M 9.75M 8.65M 8.44M 8.03M 7.08M 6.08M 6.19M 5.09M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
39.74M 39.72M 38.48M 36.74M 34.49M 35.13M 30.67M 33.25M 33.96M 33.75M 33.19M 33.6M 37.29M 33.2M 29.29M 25.5M 25.45M 22.53M 22.32M 18.38M 15.93M 13.35M
Interest Expense
281K 262K 725K 494K 414K 291K n/a 119K 134K 441K 394K 595K 409K 673K 687K 649K 647K 590K 492K 441K 433K 375K
Selling & Marketing Expenses
13.17M 11.65M 13.13M 11.67M 12.13M 12.51M 11.87M 12.43M 12.27M 12.54M 11.56M 12.08M 14.37M 11.15M 9.03M 8.81M 8.43M 6.96M 8.3M 6.55M 5.58M 4.28M
Cost & Expenses
59.54M 62.6M 67.74M 61.49M 56.23M 56.43M 54.49M 55.75M 55.14M 55.59M 58.37M 54.42M 58.82M 49.25M 48.25M 39.12M 41.05M 37.42M 37.58M 31.48M 26.6M 23.14M
Income Tax Expense
515K 1.49M 40.05M -2.29M -1.19M 136K 680K -784K 3.25M -2.82M -1.39M 2.27M -2.21M -2.23M 396K 224K -699K -1.15M 1.61M 655K 597K 50K
Shares Outstanding (Basic)
129.46M 128.7M 128.17M 127.55M 126.93M 128.34M 129.21M 131M 131.44M 130.92M 130.71M 136.17M 135.92M 135.49M 135M 134.71M 134.4M 133.9M 108.32M 108.32M 130.81M 124.82M
Shares Outstanding (Diluted)
129.46M 128.7M 128.17M 127.55M 126.93M 128.34M 129.21M 132.79M 131.44M 130.92M 130.71M 136.17M 135.92M 135.49M 137.03M 138.71M 134.4M 133.9M 113.64M 113.64M 130.81M 126.92M
EPS (Basic)
-0.09 -0.15 -0.34 -0.04 -0.04 -0.09 0.07 0.01 -0.08 -0.05 0.04 -0.05 -0.03 -0.05 0.03 0.01 0 -0.02 0 0.01 0.02 0
EPS (Diluted)
-0.09 -0.15 -0.34 -0.04 -0.04 -0.09 0.07 0.01 -0.08 -0.05 0.04 -0.05 -0.03 -0.05 0.03 0.01 0 -0.02 0 0.01 0.02 0
EBITDA
-11.36M -14.3M -263K -4.22M -3.37M -8.09M -2.45M 3.09M -4.57M -6.09M 6.93M -1.03M -4.57M -7.37M 6.67M 3.27M 112K -1.24M 1.62M 2.71M 3.9M 694K
EBIT
-11.36M -17.11M -3.31M -7.28M -6.36M -10.98M -5.19M 276K -7.05M -8.55M 4.51M -3.59M -6.19M -8.37M 4.8M 2.5M -754K -2.71M 936K 2.52M 3.7M 527K
Depreciation & Amortization
n/a 2.81M 3.04M 3.06M 2.99M 2.88M 2.74M 2.81M 2.48M 2.46M 2.43M 2.56M 1.62M 1M 1.86M 771K 866K 1.47M 685K 189K 201K 167K

© 2026 bestshares.com. All rights reserved.